As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of IVERIC bio: Wolverine Trading LLC, Walleye Trading LLC, Westchester Capital Management LLC, Woodline Partners LP, Worth Venture Partners LLC, Goldman Sachs Group Inc., Polar Asset Management Partners Inc., Citadel Advisors LLC, Tudor Investment Corp Et Al, CSS LLC IL, Shay Capital LLC, Parallax Volatility Advisers L.P., Hunting Hill Global Capital LLC, Prelude Capital Management LLC, PEAK6 Investments LLC, Soros Fund Management LLC, Sand Grove Capital Management LLP, Citigroup Inc., BNP Paribas Arbitrage SNC, Wolverine Asset Management LLC, Simplex Trading LLC, Maven Securities LTD, Fifth Lane Capital LP, Picton Mahoney Asset Management, Harvest Management LLC, Equitec Proprietary Markets LLC, and FNY Investment Advisers LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.